Patents by Inventor Heribert Stoiber

Heribert Stoiber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT FACTOR H-DERIVED SHORT CONSENSUS REPEAT-ANTIBODY CONSTRUCTS
    Publication number: 20110159018
    Abstract: The present invention relates to a complement activating construct comprising a complement factor H-derived short consensus repeat (fH-derived SCR) and a binding molecule which specifically recognizes a pathogen. More specifically, the fH-derived SCR is selected from the group consisting of SCR7, SCR9, SCR13, SCR18-20 and artificial SCR (aSCR). Furthermore, an in vivo method for screening complement-based approaches for the treatment of the prevention, treatment or amelioration of an infection with a pathogen or a pathological condition associated with an infection with a pathogen is described.
    Type: Application
    Filed: May 2, 2008
    Publication date: June 30, 2011
    Applicant: Medizinische Universitat Innsbruck
    Inventor: Heribert Stoiber
  • Inhibition of binding of complement Factor H
    Patent number: 6319890
    Abstract: Pathogen-specific peptide chains are provided which prevent pathogens from escaping complement-mediated lysis. The peptide chains bind to known binding sites on pathogens to which complement regulators such as complement Factor H bind. By occupying the binding sites and thereby preventing the binding of the complement regulators to the pathogen, the peptides prevent the pathogen from blocking or suppressing the function of the complement regulators in the complement-mediated lysis process.
    Type: Grant
    Filed: December 30, 1996
    Date of Patent: November 20, 2001
    Inventors: Manfred P. Dierich, Alberto Clivio, Heribert Stoiber